IBANDRONATO DE SÓDIO MONOIDRATADO

Product Overview

About IBANDRONATO DE SÓDIO MONOIDRATADO

IBANDRONATO DE SÓDIO MONOIDRATADO is a prescription medication used to treat and prevent bone loss conditions. It belongs to the bisphosphonate class of drugs, which work by inhibiting bone resorption and promoting bone density. The formulation contains the active ingredient ibandronate de sodium, a salt of ibandronate that enhances its stability and absorption. The medicine is typically administered orally in a single dose, often once a month, to provide sustained therapeutic effects. It is indicated for use in osteoporosis, Paget disease of bone, and other disorders that weaken bone structure. The product is manufactured under strict quality controls to ensure purity and consistency. Patients should follow the prescribing information and consult their healthcare provider for personalized guidance.

Key Benefits & Uses

• Reduces the risk of fractures in patients with osteoporosis.
• Improves bone mineral density over time.
• Provides a convenient once‑monthly dosing schedule.

Active Ingredient & Action

The active ingredient, ibandronate de sodium, binds to hydroxyapatite crystals in bone, thereby blocking osteoclast activity. This action slows bone resorption and helps maintain or increase bone mass. The sodium salt form improves solubility and facilitates oral absorption, allowing the drug to reach effective concentrations in the skeletal system.

Important Notes

IBANDRONATO DE SÓDIO MONOIDRATADO should be taken on an empty stomach with a full glass of water, and the patient should remain upright for at least 30 minutes after ingestion. Patients should avoid eating or drinking for at least 30 minutes after taking the medication. The medicine is not suitable for individuals with severe kidney impairment or those who have difficulty swallowing tablets. Always consult a healthcare professional before starting or stopping this treatment.